• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL3 通过诱导 SOCS mRNA m6A 修饰参与 Graves 病的发生。

METTL3 Is Involved in the Development of Graves' Disease by Inducing SOCS mRNA m6A Modification.

机构信息

Department of Endocrinology & Rheumatology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.

出版信息

Front Endocrinol (Lausanne). 2021 Sep 20;12:666393. doi: 10.3389/fendo.2021.666393. eCollection 2021.

DOI:10.3389/fendo.2021.666393
PMID:34616359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8488398/
Abstract

OBJECTIVE

Epigenetic modifications in RNA are known to play critical roles in cell differentiation through regulating expressions of some key genes including members of the suppressor of cytokine signaling (SOCS) family. The present study aimed to unveil the relationship of SOCS mRNA methylation induced by methyltransferase like 3 (METTL3) with Graves' disease (GD).

METHODS

Differently expressed genes (DEG) in GD tissues were identified using microarray analysis and further validated using CD4 T cell microarray of GD tissues and isolated peripheral blood mononuclear cells (PBMCs). Furthermore, expressions of METTL3 targeted genes were detected using METTL3 knock-down experiment in RAW264.7 cells.

RESULTS

High throughput microarrays revealed that METTL3 and SOCS molecules were aberrantly expressed in thyroid tissues and CD4T cells of GD compared to the controls. Bioinformatic analysis was undertaken by searching databases of found genes of the SOCS family that possessed many mRNA m6A modification loci. METTL3 knock-down experiment revealed that expressions of SOCS family members SOCS1, SOCS2, SOCS4, SOCS5, and SOCS6 were increased after METTL3 knock-down.

CONCLUSIONS

For the first time, the present study revealed the relationship between m6A modification and GD and indicated that METTL3 may be involved in the development of GD by inducing mRNA m6A methylation modification of SOCS family members.

摘要

目的

已知 RNA 中的表观遗传修饰通过调节一些关键基因(包括细胞因子信号转导抑制因子(SOCS)家族成员)的表达,在细胞分化中发挥关键作用。本研究旨在揭示甲基转移酶样 3(METTL3)诱导的 SOCS mRNA 甲基化与格雷夫斯病(GD)之间的关系。

方法

使用微阵列分析鉴定 GD 组织中的差异表达基因(DEG),并使用 GD 组织和分离的外周血单核细胞(PBMC)的 CD4 T 细胞微阵列进一步验证。此外,在 RAW264.7 细胞中通过 METTL3 敲低实验检测 METTL3 靶向基因的表达。

结果

高通量微阵列显示,与对照组相比,METTL3 和 SOCS 分子在甲状腺组织和 GD 的 CD4T 细胞中异常表达。通过搜索 SOCS 家族的发现基因数据库进行生物信息学分析,该数据库具有许多 mRNA m6A 修饰位点。METTL3 敲低实验显示,METTL3 敲低后 SOCS 家族成员 SOCS1、SOCS2、SOCS4、SOCS5 和 SOCS6 的表达增加。

结论

本研究首次揭示了 m6A 修饰与 GD 之间的关系,并表明 METTL3 可能通过诱导 SOCS 家族成员的 mRNA m6A 甲基化修饰参与 GD 的发生。

相似文献

1
METTL3 Is Involved in the Development of Graves' Disease by Inducing SOCS mRNA m6A Modification.METTL3 通过诱导 SOCS mRNA m6A 修饰参与 Graves 病的发生。
Front Endocrinol (Lausanne). 2021 Sep 20;12:666393. doi: 10.3389/fendo.2021.666393. eCollection 2021.
2
m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.m6A 甲基转移酶 METTL3 通过抑制 SOCS2 促进细胞增殖来维持结肠癌细胞的致瘤性。
Oncol Rep. 2020 Sep;44(3):973-986. doi: 10.3892/or.2020.7665. Epub 2020 Jun 26.
3
Methyltransferase METTL3 regulates neuropathic pain through m6A methylation modification of SOCS1.甲基转移酶 METTL3 通过 SOCS1 的 m6A 甲基化修饰调控神经病理性疼痛。
Neuropharmacology. 2024 Dec 15;261:110176. doi: 10.1016/j.neuropharm.2024.110176. Epub 2024 Sep 30.
4
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.RNA N6-甲基腺苷甲基转移酶样 3 通过 YTHDF2 依赖的 SOCS2 转录后沉默促进肝癌进展。
Hepatology. 2018 Jun;67(6):2254-2270. doi: 10.1002/hep.29683. Epub 2018 Apr 19.
5
Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.甲基转移酶样蛋白 3 通过加速 m6A 甲基化介导的初级 miR-663 加工和阻碍 SOCS6 表达促进肺癌进展。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3485-3499. doi: 10.1007/s00432-022-04128-5. Epub 2022 Jul 30.
6
The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy.N6-甲基腺苷 mRNA 甲基转移酶 METTL3 控制心脏稳态和肥大。
Circulation. 2019 Jan 22;139(4):533-545. doi: 10.1161/CIRCULATIONAHA.118.036146.
7
Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.失调的 N6-甲基腺苷甲基化写入器 METTL3 促进胃癌的增殖和迁移。
J Cell Physiol. 2020 Jan;235(1):548-562. doi: 10.1002/jcp.28994. Epub 2019 Jun 24.
8
The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.m6A 甲基转移酶 METTL3 介导的 DEK mRNA 的 N6-甲基腺苷化修饰促进胃癌细胞生长和转移。
Int J Mol Sci. 2022 Jun 9;23(12):6451. doi: 10.3390/ijms23126451.
9
METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.METTL3在子宫内膜样上皮性卵巢癌中独立于METTl14和WTAP调节m6A。
Cell Biol Int. 2020 Dec;44(12):2524-2531. doi: 10.1002/cbin.11459. Epub 2020 Sep 11.
10
The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.m6A 甲基转移酶 METTL3 通过调控 LEF1 的 m6A 水平促进骨肉瘤的进展。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):719-725. doi: 10.1016/j.bbrc.2019.06.128. Epub 2019 Jun 26.

引用本文的文献

1
Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications.细胞因子信号转导抑制因子在自身免疫性疾病中的研究进展:作用机制及治疗意义
Front Immunol. 2025 Jul 18;16:1604271. doi: 10.3389/fimmu.2025.1604271. eCollection 2025.
2
METTL3 overexpression and ATF6 silencing-induced Inhibition in HAS2 expression relieves PDGF-BB stimulation-induced HA production and the proliferation of human orbital fibroblasts in graves' ophthalmopathy.METTL3过表达和ATF6沉默诱导的HAS2表达抑制减轻了血小板衍生生长因子-BB(PDGF-BB)刺激诱导的透明质酸(HA)产生以及格雷夫斯眼病中人类眼眶成纤维细胞的增殖。
J Endocrinol Invest. 2025 Jul 9. doi: 10.1007/s40618-025-02647-9.
3

本文引用的文献

1
METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease.METTL3 基因多态性与自身免疫性甲状腺疾病易感性有关。
Endocrine. 2021 May;72(2):495-504. doi: 10.1007/s12020-020-02503-1. Epub 2020 Oct 6.
2
METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-B Signaling Pathway.METTL3 通过 NF-B 信号通路减轻巨噬细胞中的 LPS 诱导的炎症反应。
Mediators Inflamm. 2019 Oct 24;2019:3120391. doi: 10.1155/2019/3120391. eCollection 2019.
3
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Methyltransferase-like 3-mediated RNA N-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target.
甲基转移酶样 3 介导的 RNA N-甲基腺苷促成免疫失调:诊断生物标志物与治疗靶点。
Front Immunol. 2025 Mar 24;16:1523503. doi: 10.3389/fimmu.2025.1523503. eCollection 2025.
4
DNA and RNA Methylation in Rheumatoid Arthritis-A Narrative Review.类风湿关节炎中的DNA和RNA甲基化——一篇综述
Epigenomes. 2025 Jan 8;9(1):2. doi: 10.3390/epigenomes9010002.
5
Exploring the impact of mA modification on immune diseases: mechanisms and therapeutic implication.探讨 mA 修饰对免疫性疾病的影响:机制与治疗意义。
Front Immunol. 2024 Jul 12;15:1387582. doi: 10.3389/fimmu.2024.1387582. eCollection 2024.
6
Dysregulated N-methyladenosine modification in peripheral immune cells contributes to the pathogenesis of amyotrophic lateral sclerosis.外周免疫细胞中 N6-甲基腺苷修饰失调导致肌萎缩侧索硬化症的发病机制。
Front Med. 2024 Apr;18(2):285-302. doi: 10.1007/s11684-023-1035-5. Epub 2024 Mar 16.
7
Sequential inspiratory muscle exercise-noninvasive positive pressure ventilation alleviates oxidative stress in COPD by mediating SOCS5/JAK2/STAT3 pathway.序贯吸气肌锻炼-无创正压通气通过调节 SOCS5/JAK2/STAT3 通路减轻 COPD 中的氧化应激。
BMC Pulm Med. 2023 Oct 12;23(1):385. doi: 10.1186/s12890-023-02656-5.
8
M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.自身免疫性疾病中的 M6A 甲基化修饰:基于表观遗传学的有前景的治疗策略。
Arthritis Res Ther. 2023 Oct 2;25(1):189. doi: 10.1186/s13075-023-03149-w.
9
The role of mA RNA methylation in autoimmune diseases: Novel therapeutic opportunities.信使核糖核酸甲基化在自身免疫性疾病中的作用:新的治疗机遇。
Genes Dis. 2023 Mar 24;11(1):252-267. doi: 10.1016/j.gendis.2023.02.013. eCollection 2024 Jan.
10
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.代谢性疾病中的表观遗传调控:机制及临床研究进展。
Signal Transduct Target Ther. 2023 Mar 2;8(1):98. doi: 10.1038/s41392-023-01333-7.
RNA N6-甲基腺苷甲基转移酶样 3 通过 YTHDF2 依赖的 SOCS2 转录后沉默促进肝癌进展。
Hepatology. 2018 Jun;67(6):2254-2270. doi: 10.1002/hep.29683. Epub 2018 Apr 19.
4
The N-methyladenosine (mA)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.形成N-甲基腺苷(mA)的酶METTL3控制正常造血细胞和白血病细胞的髓系分化。
Nat Med. 2017 Nov;23(11):1369-1376. doi: 10.1038/nm.4416. Epub 2017 Sep 18.
5
mA modulates haematopoietic stem and progenitor cell specification.mA 调节造血干细胞和祖细胞的分化。
Nature. 2017 Sep 14;549(7671):273-276. doi: 10.1038/nature23883. Epub 2017 Sep 6.
6
Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease.白细胞介素-22基因变异易患自身免疫性甲状腺疾病。
Int J Endocrinol. 2017;2017:3428236. doi: 10.1155/2017/3428236. Epub 2017 Aug 3.
7
mA mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways.微小RNA(miRNA)信使核糖核酸(mRNA)甲基化通过靶向白细胞介素-7(IL-7)/信号转导子和转录激活子5(STAT5)/细胞因子信号转导抑制因子(SOCS)通路来控制T细胞稳态。
Nature. 2017 Aug 17;548(7667):338-342. doi: 10.1038/nature23450. Epub 2017 Aug 9.
8
Dynamic RNA Modifications in Gene Expression Regulation.基因表达调控中的动态RNA修饰
Cell. 2017 Jun 15;169(7):1187-1200. doi: 10.1016/j.cell.2017.05.045.
9
The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.表观遗传学在自身免疫性甲状腺疾病中的新作用
Front Immunol. 2017 Apr 7;8:396. doi: 10.3389/fimmu.2017.00396. eCollection 2017.
10
Post-transcriptional gene regulation by mRNA modifications.mRNA修饰介导的转录后基因调控。
Nat Rev Mol Cell Biol. 2017 Jan;18(1):31-42. doi: 10.1038/nrm.2016.132. Epub 2016 Nov 3.